Literature DB >> 27666491

Quality Improvement of Nasal Continuous Positive Airway Pressure Therapy in Neonatal Intensive Care Unit.

Chien-Yi Chen1, An-Kuo Chou2, Yu-Lien Chen3, Hung-Chieh Chou1, Po-Nien Tsao1, Wu-Shiun Hsieh4.   

Abstract

BACKGROUND: Nasal continuous positive airway pressure (NCPAP) therapy is widely used in neonates, but the clinical practice varies. However, nursing practice differs among individuals, and an inappropriate application method may delay the respiratory therapy, influence the beneficial effect of NCPAP, and increase complications. We introduced a quality improvement project to expedite the application of NCPAP therapy and decrease the incidence of nasal trauma.
METHODS: A new strategy of mobile NCPAP cart with prepacked fixation kits and a written protocol was implemented from April 2006. All medical staff answered a questionnaire to assess their basic knowledge before and after intensive training. The records of the patients who were treated with NCPAP from October 2005 to November 2006 were reviewed.
RESULTS: Fifty-nine medical staff were involved in the project, and their mean score for the questionnaire improved from 69.2 points to 98.3 points after training. From October 2005 to November 2006, 113 infants were recruited in total and 82 of them were admitted after the protocol was implemented. The NCPAP cart dramatically shortened the preparation time (from 520 seconds to 72 seconds) and the application time (from 468 seconds to 200 seconds). The use of the nursing protocol significantly decreased the incidence of nasal trauma in the study population (45.2% vs. 19.6%, p = 0.006), but not in infants with a birth weight of < 1000 g. Risk factors for nasal skin trauma included lower gestational age and birth weight, longer duration of NCPAP use, and lack of standardized nursing care.
CONCLUSION: The mobile NCPAP cart with prepacked fixation kits is a practical way of expediting the initiation of NCPAP therapy. The written nursing protocol decreased the incidence of nasal trauma in infants, except for those with an extremely low birth weight.
Copyright © 2016. Published by Elsevier B.V.

Entities:  

Keywords:  infants; nasal continuous positive airway pressure; nasal trauma; protocol

Mesh:

Year:  2016        PMID: 27666491     DOI: 10.1016/j.pedneo.2016.04.005

Source DB:  PubMed          Journal:  Pediatr Neonatol        ISSN: 1875-9572            Impact factor:   2.083


  6 in total

1.  Nasal Injury with Continuous Positive Airway Pressure: Need for "Privileging" Nursing Staff.

Authors:  Nihaz Naha; Femitha Pournami; Jyothi Prabhakar; Naveen Jain
Journal:  Indian J Pediatr       Date:  2019-04-24       Impact factor: 1.967

2.  Nasal Prongs: Risks, Injuries Incidence and Preventive Approaches Associated with Their Use in Newborns.

Authors:  Débora de Fátima Camillo Ribeiro; Frieda Saicla Barros; Beatriz Luci Fernandes; Adriane Muller Nakato; Percy Nohama
Journal:  J Multidiscip Healthc       Date:  2020-06-19

Review 3.  Current insights in non-invasive ventilation for the treatment of neonatal respiratory disease.

Authors:  Dhivya Lakshmi Permall; Asfia Banu Pasha; Xiao-Qing Chen
Journal:  Ital J Pediatr       Date:  2019-08-19       Impact factor: 2.638

4.  Incidence and Severity of Nasal Injuries in Preterm Infants Associated to Non-Invasive Ventilation Using Short Binasal Prong.

Authors:  Débora de Fátima Camillo Ribeiro; Frieda Saicla Barros; Beatriz Luci Fernandes; Adriane Muller Nakato; Percy Nohama
Journal:  Glob Pediatr Health       Date:  2021-04-13

5.  Implementation of neurally adjusted ventilatory assist and high flow nasal cannula in very preterm infants in a tertiary level NICU.

Authors:  Katarzyna Piątek; Liisa Lehtonen; Vilhelmiina Parikka; Sirkku Setänen; Hanna Soukka
Journal:  Pediatr Pulmonol       Date:  2022-03-14

Review 6.  Noninvasive Respiratory Support in Neonates: A Review of Current Evidence and Practices.

Authors:  Rajendra Prasad Anne; Srinivas Murki
Journal:  Indian J Pediatr       Date:  2021-06-01       Impact factor: 1.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.